Maf1 regulates axonal regeneration of retinal ganglion cells after injury

Exp Neurol. 2022 Feb:348:113948. doi: 10.1016/j.expneurol.2021.113948. Epub 2021 Dec 10.

Abstract

Retinal ganglion cells (RGCs) are the sole output neurons that carry visual information from the eye to the brain. Due to various retinal and optic nerve diseases, RGC somas and axons are vulnerable to damage and lose their regenerative capacity. A basic question is whether the manipulation of a key regulator of RGC survival can protect RGCs from retinal and optic nerve diseases. Here, we found that Maf1, a general transcriptional regulator, was upregulated in RGCs from embryonic stage to adulthood. We determined that the knockdown of Maf1 promoted the survival of RGCs and their axon regeneration through altering the activity of the PTEN/mTOR pathway, which could be blocked by rapamycin. We further observed that the inhibition of Maf1 prevented the retinal ganglion cell complex from thinning after optic nerve crush. These findings reveal a neuroprotective effect of knocking down Maf1 on RGC survival after injury and provide a potential therapeutic strategy for traumatic optic neuropathy.

Keywords: Maf1; PTEN; Regeneration; Retinal ganglion cells; Survival; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / physiology*
  • Cell Survival / physiology
  • Gene Knockdown Techniques / methods
  • Intravitreal Injections
  • Mice
  • Mice, Inbred C57BL
  • Nerve Regeneration / physiology*
  • Optic Nerve Injuries / genetics*
  • Optic Nerve Injuries / metabolism
  • Optic Nerve Injuries / pathology
  • Repressor Proteins / antagonists & inhibitors*
  • Repressor Proteins / biosynthesis
  • Repressor Proteins / genetics*
  • Retinal Ganglion Cells / physiology*

Substances

  • Maf1 protein, mouse
  • Repressor Proteins